Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Phys Rev Lett ; 119(4): 042502, 2017 Jul 28.
Artículo en Inglés | MEDLINE | ID: mdl-29341742

RESUMEN

We report the first result for the electron-antineutrino angular correlation (a coefficient) in free neutron ß decay from the aCORN experiment. aCORN uses a novel method in which the a coefficient is proportional to an asymmetry in proton time of flight for events where the ß electron and recoil proton are detected in delayed coincidence. Data are presented from a 15 month run at the NIST Center for Neutron Research. We obtained a=-0.1090±0.0030(stat)±0.0028(sys), the most precise measurement of the neutron a coefficient reported to date.

2.
Rev Sci Instrum ; 88(8): 083503, 2017 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-28863637

RESUMEN

We describe an apparatus used to measure the electron-antineutrino angular correlation coefficient in free neutron decay. The apparatus employs a novel measurement technique in which the angular correlation is converted into a proton time-of-flight asymmetry that is counted directly, avoiding the need for proton spectroscopy. Details of the method, apparatus, detectors, data acquisition, and data reduction scheme are presented, along with a discussion of the important systematic effects.

3.
Chest ; 104(1): 315-7, 1993 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-8325102

RESUMEN

Carmustine is a chemotherapeutic agent frequently employed in the treatment of malignant brain tumors. The side effect of pulmonary fibrosis occurs in 20 to 30 percent of patients receiving this drug. Herein we report a case of presumed carmustine-induced pulmonary fibrosis occurring with an unusual lobar distribution.


Asunto(s)
Carmustina/efectos adversos , Fibrosis Pulmonar/inducido químicamente , Adulto , Neoplasias Encefálicas/tratamiento farmacológico , Femenino , Glioma/tratamiento farmacológico , Humanos , Fibrosis Pulmonar/fisiopatología , Capacidad Vital/fisiología
4.
JAMA ; 250(16): 2151-6, 1983 Oct 28.
Artículo en Inglés | MEDLINE | ID: mdl-6620518

RESUMEN

The effect of 0.25 mg of terbutaline sulfate, a beta 2-adrenergic agent, on the right and left ventricular ejection fractions (RVEF and LVEF, respectively) was studied in 30 patients with severe stable chronic obstructive pulmonary disease (COPD) with a mean forced expiratory volume in 1 s of 0.79 +/- 0.06 L. All bronchodilator therapy was withdrawn 48 hours before the study. The ECG-synchronized gated equilibrium radionuclide ventriculography showed decreased RVEF in 27 patients and LVEF in 16 patients. Both the RVEF and LVEF significantly increased after the terbutaline injection; this increase was noted both in patients with normal and decreased ejection fractions. We conclude that the increase in ejection fractions after terbutaline injection may contribute to the good clinical response to this drug seen in patients with severe stable COPD even though the bronchodilator effect may be minimal.


Asunto(s)
Corazón/efectos de los fármacos , Hemodinámica/efectos de los fármacos , Enfermedades Pulmonares Obstructivas/fisiopatología , Terbutalina/farmacología , Adulto , Anciano , Volumen Espiratorio Forzado , Corazón/fisiopatología , Humanos , Masculino , Persona de Mediana Edad , Volumen Sistólico/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA